Assche Benoit Van - Net Worth and Insider Trading
Assche Benoit Van Net Worth
The estimated net worth of Assche Benoit Van is at least $375,850 dollars as of 2024-11-07. Assche Benoit Van is the President, CSS of Cytec Industries Inc and owns about 5,000 shares of Cytec Industries Inc (CYT) stock worth over $375,850. Details can be seen in Assche Benoit Van's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Assche Benoit Van has not made any transactions after 2005-03-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Assche Benoit Van
Assche Benoit Van Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Assche Benoit Van owns 2 companies in total, including Avadel Pharmaceuticals PLC (AVDL) , and Cytec Industries Inc (CYT) .
Click here to see the complete history of Assche Benoit Van’s form 4 insider trades.
Insider Ownership Summary of Assche Benoit Van
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| AVDL | Avadel Pharmaceuticals PLC | 2017-01-03 | director |
| CYT | Cytec Industries Inc | 2005-03-01 | President & CSS |
Assche Benoit Van Latest Holdings Summary
Assche Benoit Van currently owns a total of 1 stock. Assche Benoit Van owns 5,000 shares of Cytec Industries Inc (CYT) as of March 1, 2005, with a value of $375,850.
Latest Holdings of Assche Benoit Van
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CYT | Cytec Industries Inc | 2005-03-01 | 5,000 | 75.17 | 375,850 |
Holding Weightings of Assche Benoit Van
Assche Benoit Van Form 4 Trading Tracker
According to the SEC Form 4 filings, Assche Benoit Van has made a total of 0 transactions in Cytec Industries Inc (CYT) over the past 5 years. The most-recent trade in Cytec Industries Inc is the sale of 0 shares on March 1, 2005, which brought Assche Benoit Van around $0.
Insider Trading History of Assche Benoit Van
- 1
Assche Benoit Van Trading Performance
Assche Benoit Van Ownership Network
Ownership Network List of Assche Benoit Van
Ownership Network Relation of Assche Benoit Van
Assche Benoit Van Owned Company Details
What does Avadel Pharmaceuticals PLC do?
Who are the key executives at Avadel Pharmaceuticals PLC?
Assche Benoit Van is the director of Avadel Pharmaceuticals PLC. Other key executives at Avadel Pharmaceuticals PLC include Chief Financial Officer Thomas S Mchugh , director & Chief Executive Officer Greg J Divis , and Chief Commercial Officer Richard J Kim .
Avadel Pharmaceuticals PLC (AVDL) Insider Trades Summary
Over the past 18 months, Assche Benoit Van made no insider transaction in Avadel Pharmaceuticals PLC (AVDL). Other recent insider transactions involving Avadel Pharmaceuticals PLC (AVDL) include a net sale of 103,975 shares made by Mark Anthony Mccamish , a net purchase of 4,000 shares made by Thomas S Mchugh , and a net purchase of 14,000 shares made by Geoffrey Michael Glass .
In summary, during the past 3 months, insiders sold 0 shares of Avadel Pharmaceuticals PLC (AVDL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 103,975 shares of Avadel Pharmaceuticals PLC (AVDL) were sold and 43,500 shares were bought by its insiders, resulting in a net sale of 60,475 shares.
Avadel Pharmaceuticals PLC (AVDL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Avadel Pharmaceuticals PLC Insider Transactions
Assche Benoit Van Mailing Address
Above is the net worth, insider trading, and ownership report for Assche Benoit Van. You might contact Assche Benoit Van via mailing address: 10-1 Blanchardstown Corporate Park, Ballycoolin, Dublin L2 15.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
